Inappropriate prescribing of aminoglycosides: Risk factors and impact of an antibiotic control team

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 3, 2006, Pages 651-656

  Zahar, Jean Ralph ^a   Rioux, Christophe ^a   Girou, Emmanuelle ^a,b   Hulin, Anne ^a   Sauve, Colette ^a   Bernier Combes, Alexandra ^b   Brun Buisson, Christian ^a   Lesprit, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Audit; Monitoring; Prescription

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; NETILMICIN; TOBRAMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL SUPERINFECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG MONITORING; FEMALE; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NEPHROTOXICITY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TEAMWORK; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; COSTS AND COST ANALYSIS; CROSS INFECTION; DRUG UTILIZATION REVIEW; HUMANS; KIDNEY FAILURE; MIDDLE AGED; PRESCRIPTIONS, DRUG; RISK FACTORS; TREATMENT OUTCOME;

EID: 33747885880     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl288     Document Type: Article

References (18)

1. Dunagan WC, Woodward RS, Medoff G et al. Antibiotic misuse in two clinical situations: Positive blood cultures and administration of aminoglycosides. Rev Infect Dis 1991; 13: 405-12.
2. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 796-809.
3. Bailey TC, Little R, Littenberg B et al. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 786-95.
4. Brown GH, Bertino JS Jr, Rotschafer JC. Single daily dosing of aminoglycosides. A community standard? Clin Infect Dis 2000; 30: 440-1.
5. Barza M, Ioannidis JP, Cappelleri JC et al. Single or multiple daily doses of aminoglycosides: A meta-analysis. BMJ 1996; 312: 338-44.
6. Gould IM, Jappy B. Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. J Antimicrob Chemother 1996; 38: 895-904.
7. Anglim AM, Klym B, Byers KE et al. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med 1997; 157: 1132-6.
8. Working Party of the British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK. J Antimicrobial Chemother 1994; 34: 21-42.
9. Fletcher CV, Giese RM, Rodman JH. Pharmacist interventions to improve prescribing of vancomycin and tobramycin. Am J Hosp Pharm 1986; 43: 2198-201.
10. Saunders NJ, Adams DJ, Lynn WA. A prospective laboratory-based audit of gentamicin use and therapeutic monitoring. J Antimicrob Chemother 1995; 36: 729-36.
11. Li SC, Ioannides-Denos LL, Spicer WJ et al. Prospective audit of an aminoglycoside consultative service in a general hospital. Med J Aust 1992; 157: 308-11.
12. Shrimpton SB, Milmoe M, Wilson AP et al. Audit of prescription and assay of aminoglycosides in a UK teaching hospital. J Antimicrob Chemother 1993; 31: 599-606.
13. Leong CL, Buising K, Richards M et al. Providing guidelines and education is not enough: An audit of gentamicin use at the Royal Melbourne Hospital. Intern Med J 2006; 36: 37-42.
14. Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006; 42: S90-5.
15. Byl B, Clevenbergh P, Jacobs F et al. Impact of infectious disease specialists and microbiological data on the appropriateness of anti-microbial therapy for bacteremia. Clin Infect Dis 1999; 29: 60-6.
16. Fowler VG, Jr, Sanders LL, Sexton DJ et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious disease specialists; experience with 244 patients. Clin Infect Dis 1998; 27: 478-86.
17. Thuong M, Schortgen F, Zazempa V et al. Appropriate use of restricted antimicrobial agents in hospitals: The importance of empirical therapy and assisted re-evaluation. J Antimicrob Chemother 2000; 46: 501-8.
18. White AC,Jr, Atmar RL, Wilson J et al. Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25: 230-9.